Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Christian Hampp

11PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Jun 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative Study.

|Apr 01, 2026
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States.

Shaji Kumar, Katja C Weisel, Paul Spin

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

|Jun 05, 2023
Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System.

Amir Sarayani, Joshua D Brown, Christian Hampp

|Mar 20, 2023
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy.

Amir Sarayani, William Troy Donahoo, Christian Hampp

|Nov 01, 2022
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing.

Amir Sarayani, Christian Hampp, Joshua D Brown

Pageof 2

Frequent Collaborators

3 joint publications

Glenn S Kroog

3 joint publications

Alexander Breskin

3 joint publications

Almut G Winterstein

3 joint publications

Amir Sarayani

2 joint publications

Katja C Weisel

2 joint publications

Michael E D West

2 joint publications

Sundar Jagannath

2 joint publications

Rachel E Sobel

2 joint publications

Mostafa Shokoohi

2 joint publications

Shaji Kumar

Frequent Collaborators

3 joint publications

Glenn S Kroog

3 joint publications

Alexander Breskin

3 joint publications

Almut G Winterstein

3 joint publications

Amir Sarayani